Rondas de financiaciónTelecomunicaciones
Inside Information / Other news releases
13/11/2026 20:00
AMFPublicación inmediata
Rome (Italy), 13 November 2026 – Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819, the “Company”), further to its press release of 29 October 2026, announces that the second tranche of the reserved capital increase provided for under the investment agreement entered…
Mexedia S.p.A. S.B.
Via di Affogalasino, 105 - 00148
Rome RM, Italy
T: +39 (06) 94502581 mexedia.com
PEC: mexediaspa@legalmail.it
Cap. Soc.: € 57.320.000,00 i.v.
P.IVA e C.F: 15997541006
REA: 1627922
PRICE SENSITIVE
PRESS RELEASE
MEXEDIA COMPLETES THE SECOND TRANCHE OF THE RESERVED CAPITAL INCREASE
PROVIDED FOR UNDER THE INVESTMENT AGREEMENT WITH LIKAN AG
Issuance of 300,000 new shares at the fixed price of EUR 1.00 per share
Rome (Italy), 13 November 2026 – Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819, the “Company”), further to its press release of 29 October 2026, announces that the second tranche of the reserved capital increase provided for under the investment agreement entered into with Likan AG (the “Investor”) on 29 October 2026 (the “Agreement”) was completed today. The second tranche was executed under the paid capital increase resolved upon by the Extraordinary Shareholders’ Meeting on 28 October 2026, in divisible and progressive form, with exclusion of preemption rights pursuant to Article 2441, paragraph 5, of the Italian Civil Code, reserved to the Investor, for a maximum aggregate amount of EUR 20,000,000, including share premium, through the issuance of a maximum of 20,000,000 new ordinary shares at a price of EUR 1.00 per share (the “Transaction”).
Second tranche
The second tranche of the capital increase was subscribed for an amount of EUR 300,000 and fully paid up in cash by the Investor, through the issuance of 300,000 new ordinary shares of the Company (the “New Shares”), carrying the same features as the shares outstanding. The tranche forms part of the Investor’s commitment to subscribe for a total of EUR 2,500,000 within ninety days from the date of signing of the Agreement (the “Initial Commitment”).
The Company’s shares have no par value. The subscription price of EUR 1.00 per share was allocated to share capital and to the share premium reserve as follows: EUR 6,000 to share capital (EUR 0.02 per share) and EUR 294,000 to the share premium reserve (EUR 0.98 per share).
Following the issuance of the New Shares, the Company’s share capital amounts to EUR 57,346,000, represented by 9,653,129 ordinary shares with no par value.
Admission to trading
The admission to trading of the New Shares on Euronext Growth Paris is expected to occur on 18 November 2026. The issuance and the admission to trading of the New Shares do not require the Mexedia S.p.A. S.B.